Results 161 to 170 of about 2,468 (182)

Idarucizumab

Reactions Weekly, 2019
openaire   +2 more sources

Idarucizumab for dabigatran reversal: A systematic review and meta-analysis of indications and outcomes

Thrombosis Research, 2023
M V Huisman
exaly  

Idarucizumab

2021
openaire   +1 more source

Idarucizumab for the Reversal of Dabigatran

Annals of Emergency Medicine, 2017
Michael, Gottlieb, Basem, Khishfe
openaire   +2 more sources

Idarucizumab for Dabigatran Reversal Guideline

Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2016
David P, Reardon, Kent, Owusu
openaire   +2 more sources

Idarucizumab for Dabigatran Reversal in the Management of Patients With Gastrointestinal Bleeding

Circulation, 2019
Sake van der Wall, F A Klok
exaly  

Dabigatran-etexilate/idarucizumab

Reactions Weekly, 2023
openaire   +1 more source

Dabigatran-etexilate/idarucizumab

Reactions Weekly, 2019
  +4 more sources

Dabigatran etexilate/idarucizumab

Reactions Weekly, 2021
openaire   +1 more source

Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

International Journal of Stroke, 2020
Ch Nolte, Pawel Kermer, Klaus Groschel   +2 more
exaly